Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morote

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
Cancer|December 1, 1996
Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigenJ Morote, J A Lorente, G Encabo
Actas Urologicas Espanolas|June 1, 1994
[Fluamide withdrawal syndrome]J Morote, J A Lorente, C Vallejo
Actas Urologicas Espanolas|February 23, 2016
Measurement of serum testosterone during androgenic suppression in patients with prostate cancer: A systematic reviewJ Morote, L Regis, A Celma, et al.
Actas Urologicas Espanolas|January 1, 1993
[False elevation of PSA in women and patients with renal cancer]D J Morote Robles, M A López Pacios
Actas Urologicas Espanolas|May 23, 2016
Utility of the RENAL index -Radius; Exophytic/endophytic; Nearness to sinus; Anterior/posterior; Location relative to polar lines- in the management of renal massesC Konstantinidis, E Trilla, D Lorente, et al.
Actas Urologicas Espanolas|May 29, 2014
Non-metastatic castration-resistant prostate cancer (CPRCM0), an old scenario with renewed clinical interestJ Morote, J Planas, X Maldonado, et al.
European Urology|July 15, 2000
Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancerJ Morote, G Encabo, I M de Torres
Archivos Espanoles De Urologia|January 1, 1989
[Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]J Morote Robles, J A de Torres Mateos
Medicina Clinica|December 7, 1996
[Clinical usefulness of the free and total prostate specific antigen ratio in the diagnosis of cancer of the prostate]J Morote, G Encabo, J Andreu, et al.
Actas Urologicas Espanolas|December 3, 1998
[Antiandrogen suppression syndrome in patients with hormone-resistant cancer of the prostate]J Morote Robles, J A Lorente Garín, G Encabo
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
Cancer|December 1, 1996
Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigenJ Morote, J A Lorente, G Encabo
Actas Urologicas Espanolas|June 1, 1994
[Fluamide withdrawal syndrome]J Morote, J A Lorente, C Vallejo
Actas Urologicas Espanolas|February 23, 2016
Measurement of serum testosterone during androgenic suppression in patients with prostate cancer: A systematic reviewJ Morote, L Regis, A Celma, et al.
Actas Urologicas Espanolas|January 1, 1993
[False elevation of PSA in women and patients with renal cancer]D J Morote Robles, M A López Pacios
Actas Urologicas Espanolas|May 23, 2016
Utility of the RENAL index -Radius; Exophytic/endophytic; Nearness to sinus; Anterior/posterior; Location relative to polar lines- in the management of renal massesC Konstantinidis, E Trilla, D Lorente, et al.
Actas Urologicas Espanolas|May 29, 2014
Non-metastatic castration-resistant prostate cancer (CPRCM0), an old scenario with renewed clinical interestJ Morote, J Planas, X Maldonado, et al.
European Urology|July 15, 2000
Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancerJ Morote, G Encabo, I M de Torres
Archivos Espanoles De Urologia|January 1, 1989
[Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate]J Morote Robles, J A de Torres Mateos
Medicina Clinica|December 7, 1996
[Clinical usefulness of the free and total prostate specific antigen ratio in the diagnosis of cancer of the prostate]J Morote, G Encabo, J Andreu, et al.
Actas Urologicas Espanolas|December 3, 1998
[Antiandrogen suppression syndrome in patients with hormone-resistant cancer of the prostate]J Morote Robles, J A Lorente Garín, G Encabo
Pageof 21